- On the Horizon
- Rate cuts provide opportunities for U.S. small-caps and financials
- Valuations remain stretched, but the market is broadening.
- 2024-11-15 22:09
U.S. equity returns were dominated by three themes in 2024: one, the rise of artificial intelligence (AI) and its derivatives; two, the strong performance of rate‑sensitive cyclical stocks in anticipation of Fed cuts; and three, soaring valuations of perceived “safe bets” despite unchanged earnings growth. In 2025, all three of these themes could unwind.
The growth rate of AI infrastructure is likely to slow due to increased competition. Cyclical stocks’ valuations are currently high after strong performance this year, although their risk/reward profile is more mixed for 2025. Many of the stocks are now at or near all‑time high valuations, with low expected growth rates.
Valuations are high across most sectors
Stretched valuations suggest that U.S. stocks will underperform bonds in the medium term (Figure 1). However, a combination of improving earnings and lower rates could result in a soft landing. We believe the Fed will continue to be data‑dependent when determining the speed and extent of the rate‑cutting cycle.
U.S. equity valuations are close to historic highs in many sectors
(Fig. 1) Returns may underperform bonds in the medium term
Past performance is not a reliable indicator of future performance.
As of October 31, 2024.
Time period range to determine the current relative valuation percentile as of October 31, 2024 is January 31, 1990 through October 31, 2024. Valuations are calculated monthly. Source: Standard & Poor’s, via FactSet (see Additional Disclosures). Analysis by T. Rowe Price.
That said, we see a broadening opportunity set in U.S. equity markets, spanning several sectors. Small‑caps, which are trading at a historic discount to large‑caps, should benefit from further rate cuts and any signs of an improving economy. In addition, the current position of the energy cost curve indicates that we could be in for a multiyear regime change of capex and investment spend in energy, which would also benefit small‑cap stocks.
From a sector perspective, financials looks interesting. After Fed rate increases led to such poor performance for banks and real estate investment trusts in 2024, the market is anticipating better performance for this rate‑sensitive group should rate cuts continue into 2025. Energy has also underperformed significantly over the past year, but we see reasonable upside potential in several subsectors. Natural gas is attractive and likely to outperform due to limiting supply from rig count restrictions and pipeline constraints, and there is a longer‑term case for carbon‑based fuels owing to slower technological productivity gains and a delay in peak demand until after 2035.
Broader opportunities signal a stock pickers’ market
We see company‑specific opportunities in industrials given the normalization of markets following the post‑COVID volatility. Most of these are in aerospace, electrical contractors, agriculture, municipal spending, and consumer‑related building products. In health care, the life sciences sector appears likely to benefit from a reacceleration of growth in biopharma production and as early‑stage research picks back up after some major patent expirations among large pharmaceutical firms.
Elsewhere, there are plenty of software firms that were not immediate beneficiaries of AI that have strong earnings growth prospects and are attractively valued. Although utilities have traded higher recently, the sector should benefit from rising demand due to AI, and is therefore likely to deliver faster earnings growth.
Overall, we anticipate a continued expansion of investible opportunities, characterized by historically attractive valuations in certain sectors, the normalization of fundamental trends post‑COVID, and improvement in growth aided by lower interest rates and fiscal support.
Key takeaway
The key trends that dominated U.S. equities in 2024 may fade in 2025, but this will likely expand the opportunity set.
ETFs are bought and sold at market prices, not NAV. Investors generally incur the cost of the spread between the prices at which shares are bought and sold. Buying and selling shares may result in brokerage commissions which will reduce returns.
-
Financial Terms: For a Glossary of financial terms, please go to: www.troweprice.com/en/us/glossary
Investment Risks
Commodities are subject to increased risks such as higher price volatility, geopolitical and other risks. Commodity prices can be subject to extreme volatility and significant price swings.Investing in technology stocks entails specific risks, including the potential for wide variations in performance and usually wide price swings, up and down. Technology companies can be affected by, among other things, intense competition, government regulation, earnings disappointments, dependency on patent protection and rapid obsolescence of products and services due to technological innovations or changing consumer preferences. Financial services companies may be hurt when interest rates rise sharply and may be vulnerable to rapidly rising inflation. Health sciences firms are often dependent on government funding and regulation and are vulnerable to product liability lawsuits and competition from low-cost generic product.
Because of the cyclical nature of natural resource companies, their stock prices and rates of earnings growth may follow an irregular path.
The value approach to investing carries the risk that the market will not recognize a security’s intrinsic value for a long time or that a stock judged to be undervalued may actually be appropriately priced.
Small‑cap stocks have generally been more volatile in price than the large‑cap stocks.
All investments involve risk, including possible loss of principal.
T. Rowe Price cautions that economic estimates and forward‑looking statements are subject to numerous assumptions, risks, and uncertainties, which change over time. Actual outcomes could differ materially from those anticipated in estimates and forward‑looking statements, and future results could differ materially from any historical performance. The information presented herein is shown for illustrative, informational purposes only. Any historical data used as a basis for this analysis are based on information gathered by T. Rowe Price and from third‑party sources and have not been independently verified. Forward‑looking statements speak only as of the date they are made, and T. Rowe Price assumes no duty to and does not undertake to update forward‑looking statements.
Additional Disclosures
For more information on Third Party Market Data please visit troweprice.com/marketdata.
-
Important Information
This material is provided for informational purposes only and is not intended to be investment advice or a recommendation to take any particular investment action.
The views contained herein are those of the authors as of November 2024 and are subject to change without notice; these views may differ from those of other T. Rowe Price associates.
This information is not intended to reflect a current or past recommendation concerning investments, investment strategies, or account types, advice of any kind, or a solicitation of an offer to buy or sell any securities or investment services. The opinions and commentary provided do not take into account the investment objectives or financial situation of any particular investor or class of investor. Please consider your own circumstances before making an investment decision.
Information contained herein is based upon sources we consider to be reliable; we do not, however, guarantee its accuracy.
Past performance is not a reliable indicator of future performance. All investments are subject to market risk, including the possible loss of principal. All charts and tables are shown for illustrative purposes only.
T. Rowe Price Investment Services, Inc., distributor, T. Rowe Price mutual funds. T. Rowe Price Investment Management, Inc., investment adviser. T. Rowe Price Investment Services, Inc. and T. Rowe Price Investment Management, Inc., are affiliated companies.
© 2024 T. Rowe Price. All Rights Reserved. T. Rowe Price, INVEST WITH CONFIDENCE, and the Bighorn Sheep design are, collectively and/or apart, trademarks of T. Rowe Price Group, Inc.
202411-4019613